Deciphering the code: Advancing therapies for endometriosis and cancer with DNA-encoded drug discovery

Wei Yan
Proceedings of the National Academy of Sciences of the United States of America · 2024 · vol. 121(23) , pp. e2407555121 · doi:10.1073/pnas.2407555121 · PMID:38781225 · PMC11161770
other OA: gold CC-BY-NC-ND-4.0
📄 Open PDF View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-07, 2026-07-29 ⓘ

This paper describes DNA-encoded drug discovery as a method to advance therapies for both endometriosis and cancer.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Drug Discovery Drug Discovery Drug Discovery Drug Discovery Drug Discovery Drug Discovery Drug Discovery Drug Discovery Drug Discovery Drug Discovery Drug Discovery Drug Discovery Drug Discovery Drug Discovery Drug Discovery Drug Discovery Drug Discovery Drug Discovery Drug Discovery Drug Discovery

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2024) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-07-30T06:25:42.655704+00:00
pubmed
last seen: 2026-07-30T06:18:43.708368+00:00
unpaywall
last seen: 2026-05-14T19:30:52.867331+00:00
License: CC-BY-NC-ND-4.0 · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine